跳至主導覽
跳至搜尋
跳過主要內容
國立陽明交通大學研發優勢分析平台 首頁
English
中文
在 國立陽明交通大學研發優勢分析平台 搜尋內容
首頁
人員
單位
研究成果
計畫
獎項
活動
貴重儀器
影響
衛生保健組
國立陽明交通大學
學生事務處
概覽
指紋
網路
人員
(1)
計畫
(7)
研究成果
(58)
指紋
查看啟用 衛生保健組 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Keyphrases
Action-research Approach
6%
Apparent Diffusion Coefficient
7%
Area under the Curve
13%
Artificial Intelligence
20%
Astrogliosis
7%
Atrial Fibrillation Recurrence
6%
Atrium
8%
Brain Injury
9%
Brain Metastases
14%
Catheter Ablation
6%
Clinical Features
25%
Clinical Outcome Prediction
10%
Closed Head Injury
10%
Cognitive Task
7%
Computational Modeling
12%
Computed Tomography
9%
Computed Tomography Images
9%
Concordance Index
8%
Connectivity Change
6%
Convolutional Neural Network
12%
Cortical Activation
8%
Curvedness
6%
Deep Learning
24%
Deep Learning Methods
21%
Deep Learning Model
8%
Diffusion Tensor Imaging
11%
Disease Progression
6%
Drop Weight
12%
Dropping Function
12%
Elementary School
7%
Epicardial Adipose Tissue
12%
Epidermal Growth Factor Receptor
16%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
18%
Family Partnership
6%
Family-school Partnerships
6%
Fractional Anisotropy
13%
Functional Connectivity
11%
Gait Performance
7%
Gamma Knife Radiosurgery
20%
Glioblastoma
7%
Gray Matter
9%
Health Promoting Schools
18%
Health Promotion
6%
Healthy Controls
9%
Imaging Biomarkers
7%
Immunotherapy Response
12%
Individualized Prediction
13%
Left Atrium
9%
Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)
9%
Lung Cancer
20%
Lung Cancer Brain Metastases
18%
Lung Cancer Patients
21%
Magnetic Resonance
6%
Magnetic Resonance Imaging
41%
Meta-analysis
18%
Mild Traumatic Brain Injury (mTBI)
15%
Model Modification
12%
Molecular Subtypes
12%
Motor Evoked Potential
7%
Multiparametric MRI (mpMRI)
12%
Nanoparticles
7%
Near-infrared Spectroscopy
24%
Neuro-oncology
12%
Neuroimaging
6%
Non-small Cell Lung Cancer (NSCLC)
29%
Non-small Cell Lung Cancer Patients
10%
Older Adults
7%
Outcome Prediction
7%
Overall Survival
9%
Pediatric Cochlear Implantation
12%
Perfusion
6%
Predictive Models
10%
Primary School
6%
Progression-free Survival
25%
Quantitative MRI
6%
Radiomics
100%
Radiosurgery
25%
Radiotherapy
7%
Regional Cerebral Blood Flow (rCBF)
6%
Repetitive Transcranial Magnetic Stimulation (rTMS)
9%
Resting-state Functional Connectivity (rs-FC)
6%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
6%
Sentence Recognition
9%
Sham
8%
Stereotactic Radiosurgery
10%
Survival Curve
7%
Survival Prediction
11%
Systematic Meta-analysis
18%
T1-weighted
12%
T2-weighted Imaging (T2WI)
11%
Taiwan
31%
Taiwanese
7%
Traumatic Brain Injury Models
12%
Treatment Planning
7%
Treatment Response
7%
Tumor
11%
Tyrosine Kinase Inhibitor
6%
Tyrosine Kinase Inhibitor Treatment
8%
Vestibular Schwannoma
19%
White Matter
7%
Neuroscience
Acoustic Neuroma
24%
Anisotropy
8%
Arcuate Fasciculus
6%
Arteriovenous Malformation
6%
Astrogliosis
5%
Bipolar Disorder
6%
Brain Activation
13%
Brain Cancer
12%
Cerebrovascular Accident
33%
Closed Head Injury
10%
Cochlea
12%
Computed Tomography
9%
Corpus Callosum
6%
Dexmedetomidine
6%
Diffusion Tensor Imaging
10%
Electroencephalogram
7%
Epidermal Growth Factor Receptor
29%
Fractional Anisotropy
17%
Functional Connectivity
20%
Functional Magnetic Resonance Imaging
9%
Functional near Infrared Spectroscopy
30%
Gait
6%
Generalized Anxiety Disorder
6%
Gray Matter
9%
Headache
6%
Heart Rate Variability
6%
Hemiplegia
6%
Immunotherapy
18%
In Vitro
6%
Intracranial Tumor
12%
Ischemia
6%
Isocitrate Dehydrogenase
6%
Isoflurane
6%
Machine Learning Algorithm
12%
Magnetic Resonance Imaging
48%
Magnetic Resonance Imaging
17%
Medulloblastoma
6%
Meningioma
6%
Meta-Analysis
12%
Mild Cognitive Impairment
6%
Motor Evoked Potential
10%
Nervous System Disorder
7%
Neural Network
17%
Neurotrauma
23%
Positron Emission Tomography
6%
Prefrontal Cortex
11%
Premotor Cortex
6%
Receptor Tyrosine Kinase Inhibitors
9%
Resting-State Functional Connectivity
6%
Sensation of Hearing
6%
Serotonin
6%
Stenosis
6%
Transcranial Direct Current Stimulation
6%
Transcranial Magnetic Stimulation
15%
Traumatic Brain Injury
23%
Tyrosine Kinase Inhibitor
15%
Verbal Memory
6%
Working Memory
6%